Aripiprazole-induced Tardive Dyskinesia in 13 Years Old Girl Successfully Treated with Biperiden: A Case Report.
10.9758/cpn.2017.15.3.285
- Author:
Marco LAMBERTI
1
;
Gabriella DI ROSA
;
Francesca CUCINOTTA
;
Erica PIRONTI
;
Cecilia GALATI
;
Antonella GAGLIANO
Author Information
1. Division of Child Neurology and Psychiatry, Department of Pediatrics, University of Messina, Messina, Italy. mlamberti@unime.it, marcolb@yahoo.it
- Publication Type:Case Report
- Keywords:
Antipsychotics;
Drug side effects;
Tardive dyskineisa;
Movement disorders;
Pediatrics
- MeSH:
Antipsychotic Agents;
Aripiprazole;
Biperiden*;
Drug-Related Side Effects and Adverse Reactions;
Dyskinesias;
Female*;
Humans;
Intellectual Disability;
Long Term Adverse Effects;
Mood Disorders;
Movement Disorders*;
Pediatrics;
Problem Behavior
- From:Clinical Psychopharmacology and Neuroscience
2017;15(3):285-287
- CountryRepublic of Korea
- Language:English
-
Abstract:
In the last years second-generation antipsychotics are increasingly prescribed in the pediatric population for the treatment of several psychiatric disorders. Among the long term adverse effects, extrapyramidal symptoms (EPS) are less reported compared to first-generation antipsychotics. Tardive dyskinesia (TD) is a iatrogenic rare syndrome characterized by persistent slow writhing and sudden involuntary movements mainly involving the oral-buccal-lingual area with masticatory movements. We report a young girl with mood disorders accompanied by mild intellectual disability and behavioral problems who had TD after treatment with Aripiprazole, which responded to Biperiden therapy.
